An investigation of the wear behavior, in lubricated sliding and rolling of in situ prepared TiB 2 particle-reinforced 2024 T4 Al alloy matrix composites against 52100 steel and hardened pearlitic nodular cast iron, respectively, was undertaken. In sliding contact, the 10 vol pct 0.3-m TiB 2 -metal matrix composite (MMC) showed slightly less wear than the 10 vol pct 1.3-m TiB 2 -MMC. Transmission electron microscopy of cross sections, taken normal to the wear track and parallel to the sliding direction, revealed that the TiB 2 particles on the wear track were polished and particle pullout was largely absent. This was attributed to the strong interfacial bonding between the Al-alloy matrix and the TiB 2 reinforcing phase. The TiB 2 particles on the wear track inhibited spalling. Subsurface damage of the MMC did not occur. The wear of the steel mating surfaces worn against the TiB 2 -MMCs was minor and caused by the cutting action of the TiB 2 particles that resided on the MMC wear track. In rolling contact, the 0.3-m-size TiB 2 -MMC showed 5 times higher weight loss than the 1.3-m TiB 2 -MMC for the same content of reinforcement, but the weight loss of the cast iron mating surface was less for the former. For the smaller particle size, the wear of 5 and 10 vol pct TiB 2 -MMCs was the same. A high density of surface cracks was present on the wear track of the 0.3-m TiB 2 -MMC but not on the 1.3-m MMC. The significance of strong particle/matrix interfacial bonding and particle size effect on the wear behavior of ceramic particulate-reinforced MMCs in lubricated sliding and rolling wear is discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.